This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Food Allergy
and you are
between 6 and 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Cow's milk (CM) allergy is the most common food allergy in children, affecting 2-3% of infants. In formula-fed infants with CM allergy, extensively hydrolyzed or amino acid-based infant formulas are typically recommended. These formulas are expensive and not palatable. For older patients with CM allergy, the standard of care is avoidance of all CM products. The investigators cared for a CM allergic patient who was able to tolerate partially hydrolyzed whey formula (pHWF), which tastes better and is less expensive than extensively hydrolyzed or amino-acid based formulas. There are likely other subjects who could similarly tolerate pHWF. Furthermore, it is possible that taking pHWF could accelerate tolerance of CM. The investigators aim to identify characteristics of CM allergic subjects who can tolerate pHWF and assess the degree to which taking pHWF accelerates CM tolerance.

Provided treatments

  • Other: Partially Hydrolyzed Whey formula
Tris trial is registered with FDA with number: NCT02397876. The sponsor of the trial is Icahn School of Medicine at Mount Sinai and it is looking for 10 volunteers for the current phase.
Official trial title:
Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients